Flupentixol
General information:
| Withdrawn ID: | DB00875 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | N05AF01 |
| Molecular Formula: | C23H25F3N2OS |
| Molweight: | 434.52 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|
Side-effects:
| Total reported cases (submitted by medical professionals) with Flupentixol as primary suspect: | 2 |
|---|
Reported final outcomes:
| Hospitalization (initial or prolonged): | 2 |
|---|---|
| Disability: | 1 |
Reported side-effects:
| Side-effect | Case number |
|---|---|
| Neuroleptic malignant syndrome | 1 |
| DRUG INTERACTION | 1 |
| Compartment syndrome | 1 |
| Brachial plexus injury | 1 |
| BLOOD CREATINE PHOSPHOKINASE INCREASED | 1 |
Filtered ChEMBL targets:
| Target UniProtKB ID | Activity in nm | Target Name | Target gene |
|---|---|---|---|
| O95069 | 2000 | Potassium channel subfamily K member 2 | KCNK2_HUMAN |
| Q8TAF3 | 7000 | WD repeat-containing protein 48 | WDR48_HUMAN |
Toxicity information:
| Toxicity type: | N/A |
|---|
External links:
| ChEBML: | CHEMBL54661 |
|---|---|
| DrugBank: | DB00875 |